|
Group
|
TG
|
CG
|
P-Value
|
|---|
|
N
|
32
|
30
| |
|
Gender (male/female)
|
26/6
|
22/8
|
.79
|
|
Age (years)
|
64.1 ± 10.9
|
69.1 ± 9.2
|
.27
|
|
BMI (kg/m
2
)
|
27.6 ± 6.7
|
27.0 ± 4.9
|
.87
|
|
Resting SpO
2
Saturation
|
95.4 ± 1.7
|
94.3 ± 3.6
|
.095
|
|
FEV
1
(%)
|
50.2 ± 15.0
|
52.6 ± 17.5
|
.731
|
|
PEF (L/min)
|
3.7 ± 1.23
|
4.4 ± 1.4
|
.194
|
|
MMRC
|
1.9 ± 1.1
|
1.2 ± 0.93
|
.125
|
|
GOLD
|
2.6 ± 0.8
|
2.5 ± 0.9
|
.83
|
|
BODE
|
3.2 ± 3.1
|
2.9 ± 3.0
|
.55
|
|
SGRQ
|
51.3 ± 18.7
|
48.7 ± 14.7
|
.56
|
|
COPD Medication
| | | |
|
Long AC
|
25 (78%)
|
22 (73%)
|
.33
|
|
ICS/LABA
|
23 (72%)
|
21 (70%)
|
.46
|
- Characteristics of patient population; data is presented as Mean ± SD; group comparisons of measurements across between Tele-monitoring group (TG) and control group (CG) were done using a two tailed student’s t-test and χ2-test. BMI = Body Mass Index; SpO2 = resting oxygen saturation; FEV1 (L) = Forced Expiratory Volume in one second; PEF = Peak Expiratory Flow; MMRC = Modified Medical Research Council Dyspnea Scale; SGRQ = St. George Respiratory Questionnaire; Long AC = Long Acting Anticholinergic; ICS/LABA = fix combination of ICS/LABA.
